Emerging markets represent a major opportunity for pharmaceutical companies seeking revenue growth. To capture it, they need to make a rapid shift from traditional marketing and sales approaches to access-driven commercial models. Although access needs to be owned and driven at country level, some activities still need to take place at regional level, such as connecting stakeholders (for example, region-wide patient organizations), facilitating data collection and analysis, and sharing best practices between markets.
Saarathi with its team spread across varied geographic locations, work with regional stakeholders to understand regional specific barriers from patients’ point of view. Do barriers lie in awareness or affordability or a local culture that considers the disease a taboo??
Working in tandem with informal networks and local NGOs help us understand both the local access landscape and the stakeholders who shape it. Accordingly, we create region specific access strategy for different therapies. With our profound understanding of patient needs, we work with local care givers to educate and empower patients for better wellness and treatment outcomes.